Elena B.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase 1b Study of OMTX705 in Patients with Advanced/Metastatic Pancreatic Adenocarcinoma
- Phase III Randomized Controlled Trial Evaluating Tinengotinib Versus Physician's Choice in FGFR-Altered, Chemotherapy- and FGFR Inhibitor-Refractory Cholangiocarcinoma
- Phase 2 Randomized Study of Valproic Acid, Simvastatin, and Gemcitabine/Nab-Paclitaxel Regimens in Metastatic Pancreatic Ductal Adenocarcinoma
Data & Insights
Has run more than one trial at 23 of 74 partner sites.
Specializations
Oncology Specialization
This investigator specializes in treating cholangiocarcinoma, focusing on advanced therapeutic approaches for biliary tract cancers.
- Bile Duct Cancer Treatment
- Advanced Therapeutic Strategies
- Targeted Cancer Therapies
The investigator's work encompasses treating patients with unresectable or metastatic disease states.
Molecular Oncology
Expertise in FGFR2 rearrangement targeted therapies, demonstrating a focus on precision medicine approaches in gastrointestinal cancers.
- Genetic Biomarker Analysis
- Personalized Treatment Strategies
- Molecular Profiling
The investigator applies molecular diagnostics to guide treatment selection for optimal patient outcomes.
First-Line Treatment Innovation
Specializes in evaluating novel therapeutic approaches for first-line treatment of biliary tract malignancies.
- Treatment Optimization
- Comparative Therapy Assessment
- Clinical Efficacy Evaluation
The investigator focuses on advancing treatment standards for newly diagnosed patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.